Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Guardant Health Inc (GH)

Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Guardant Health to Report First Quarter 2026 Financial Results on May 7, 2026

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the first quarter 2026 after market close on Thursday, May 7, 2026. Company...

GH : 91.07 (+0.79%)
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know

Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know

FTRE : 10.44 (+0.58%)
GH : 91.07 (+0.79%)
OGN : 9.26 (-5.12%)
CRL : 185.54 (+0.90%)
QDEL : 12.89 (+1.42%)
1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds

1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds

GH : 91.07 (+0.79%)
VRTX : 439.18 (-0.46%)
OCUL : 9.52 (-3.05%)
Why Is Guardant Health (GH) Stock Soaring Today

Why Is Guardant Health (GH) Stock Soaring Today

GH : 91.07 (+0.79%)
Guardant Health’s InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan

This milestone underscores the power of Guardant Health’s InfinityAI platform and real-world data to enable innovative evidence generation in rare biomarker-defined populations

GH : 91.07 (+0.79%)
Why Guardant Health (GH) Stock Is Falling Today

Why Guardant Health (GH) Stock Is Falling Today

GH : 91.07 (+0.79%)
3 Growth Stocks We Think Twice About

3 Growth Stocks We Think Twice About

GH : 91.07 (+0.79%)
ROOT : 55.67 (+1.77%)
RUN : 12.18 (-1.77%)
Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data

Combination of high quality, variable-rich, curated EHR data with genomics enhances understanding of the patient journey and aids in therapy development  

GH : 91.07 (+0.79%)
3 Reasons to Avoid GH and 1 Stock to Buy Instead

3 Reasons to Avoid GH and 1 Stock to Buy Instead

GH : 91.07 (+0.79%)
Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026

Guardant Reveal demonstrates expanded utility in identifying new, primary cancers during minimal residual disease (MRD) monitoring Studies show strong...

GH : 91.07 (+0.79%)

Barchart Exclusives

Tilray Stock Pops on New Trump-Driven Cannabis Hopes. Should You Chase the Rally?
Tilray shares rally as Trump urges the DOJ to quickly reclassify cannabis as a Schedule III drug. Options pricing suggests TLRY stock could rip higher through mid-September. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.